Ekso Bionics Holdings Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 77/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 7.75.In the medium term, the stock price is expected to remain stable.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Ekso Bionics Holdings Inc's Score
Industry at a Glance
Industry Ranking
77 / 208
Overall Ranking
188 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Buy
Current Rating
7.750
Target Price
+75.34%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Ekso Bionics Holdings Inc Highlights
StrengthsRisks
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 38.82% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 17.93M.
Overvalued
The company’s latest PE is -0.90, at a high 3-year percentile range.
Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
Ticker SymbolEKSO
CompanyEkso Bionics Holdings Inc
CEODavis (Scott G)
Websitehttps://eksobionics.com/
FAQs
What is the current price of Ekso Bionics Holdings Inc (EKSO)?
The current price of Ekso Bionics Holdings Inc (EKSO) is 4.860.
What is the symbol of Ekso Bionics Holdings Inc?
The ticker symbol of Ekso Bionics Holdings Inc is EKSO.
What is the 52-week high of Ekso Bionics Holdings Inc?
The 52-week high of Ekso Bionics Holdings Inc is 14.975.
What is the 52-week low of Ekso Bionics Holdings Inc?
The 52-week low of Ekso Bionics Holdings Inc is 2.730.
What is the market capitalization of Ekso Bionics Holdings Inc?
The market capitalization of Ekso Bionics Holdings Inc is 12.75M.
What is the net income of Ekso Bionics Holdings Inc?
The net income of Ekso Bionics Holdings Inc is -11.33M.
Is Ekso Bionics Holdings Inc (EKSO) currently rated as Buy, Hold, or Sell?
According to analysts, Ekso Bionics Holdings Inc (EKSO) has an overall rating of Buy, with a price target of 7.750.
What is the Earnings Per Share (EPS TTM) of Ekso Bionics Holdings Inc (EKSO)?
The Earnings Per Share (EPS TTM) of Ekso Bionics Holdings Inc (EKSO) is -5.410.